Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 245s Year: 2001
Severe exacerbations, decline in lung function and inhaled budesonide in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007
Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003
Efficacy of inhalation from different powder inhalators in COPD patiens with chronic respiratory failure Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
The role of nebulised budesonide in the treatment of exacerbations of COPD Source: Eur Respir J 2007; 29: 660-667 Year: 2007
Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006
Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Alveolar absorption and systemic bioactivity of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004
Functional respiratory imaging assessment of the aerosol deposition of inhaled levofloxacin in cystic fibrosis lungs Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021
Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Tolerance test for inhaled antibiotics in patients with chronic bronchial infection Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018
Efficacy of symbicort administration in patients with bronchial asthma Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Clinical efficacy of nebulised budesonide in acute exacerbation of COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Comparison of fluticasone propionate and budesonide on phagocytosis of common respiratory pathogens in COPD patients Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011
IPF exacerbations: Role of Respiratory tract infections Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018